663. Efficacy and Safety of Lefamulin (LEF) vs. Moxifloxacin (MOX) for Legionella pneumophila (LP) in Patients with Community-Acquired Bacterial Pneumonia (CABP): Pooled Results From the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Phase 3 Clinical Trials
Saved in:
| Title: | 663. Efficacy and Safety of Lefamulin (LEF) vs. Moxifloxacin (MOX) for Legionella pneumophila (LP) in Patients with Community-Acquired Bacterial Pneumonia (CABP): Pooled Results From the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Phase 3 Clinical Trials |
|---|---|
| Authors: | Shorr, Andrew F1 (AUTHOR), Schranz, Jennifer2 (AUTHOR), Goldberg, Lisa2 (AUTHOR), Paukner, Susanne3 (AUTHOR), Das, Anita F4 (AUTHOR), Moran, Gregory J5 (AUTHOR), Sandrock, Christian6 (AUTHOR), File, Thomas M7 (AUTHOR), Alexander, Elizabeth2 (AUTHOR), Gelone, Steven P2 (AUTHOR) |
| Source: | Open Forum Infectious Diseases. 2019 Supplement, Vol. 6, pS303-S304. 2p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
